Osteofos 70mg (Alendronate sodium Tablet) 70mg

Osteofos 70mg (Alendronate sodium) is a bisphosphonate tablet prescribed for bone health. It helps reduce bone loss and supports osteoporosis management. This 70mg strength tablet is commonly used for weekly dosing. Store at ambient temperature for stability.

Strength

70mg

Pack Size

40s

Storage

Ambient

Manufacturer / TM Owner

Cipla Ltd.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Osteofos 70mg is primarily used to treat and prevent osteoporosis in postmenopausal women. It may also be prescribed for men and individuals with osteoporosis caused by long-term steroid use. The medication works by slowing bone breakdown, helping maintain bone density. It is not a pain reliever but supports overall bone strength.

Side Effects

Osteofos 70mg helps reduce the risk of fractures by supporting bone mineral density. Users may notice improved bone health over time with consistent use. Some individuals report mild gastrointestinal discomfort when taking the tablet. It is designed for long-term use to maintain skeletal integrity.

Precautions & Warnings

Take Osteofos 70mg with a full glass of water to prevent throat irritation. Remain upright for at least 30 minutes after taking the tablet to reduce the risk of esophageal issues. Avoid lying down immediately after administration. Consult a healthcare provider if you experience persistent stomach pain or heartburn.

Avoid Interactions

Certain medications, such as antacids or calcium supplements, may interfere with Osteofos 70mg absorption. Avoid taking other oral medications within 30 minutes of this tablet. Alcohol and tobacco may reduce the effectiveness of the treatment. Always inform your doctor about all medications and supplements you are using.

Frequently Asked Questions

Osteofos 70mg is used to treat and prevent osteoporosis by slowing bone loss and improving bone density.

Take one tablet weekly with a full glass of water and remain upright for 30 minutes after dosing.

Take Osteofos 70mg on an empty stomach for best absorption; avoid food for at least 30 minutes after dosing.

Common side effects include mild stomach upset or heartburn; severe side effects are rare but should be reported to a doctor.

Osteofos 70mg is designed for long-term use to maintain bone health, but regular medical supervision is recommended.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.